500 related articles for article (PubMed ID: 17039566)
21. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response.
Caspi RR; Silver PB; Chan CC; Sun B; Agarwal RK; Wells J; Oddo S; Fujino Y; Najafian F; Wilder RL
J Immunol; 1996 Sep; 157(6):2668-75. PubMed ID: 8805672
[TBL] [Abstract][Full Text] [Related]
22. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
[TBL] [Abstract][Full Text] [Related]
23. Inducible co-stimulator (ICOS) is upregulated in experimental autoimmune uveoretinitis.
Xing L; Yang P; Wu C; Jin H; Chen X; Gao Y; Li B; Huang X; Zhou H
Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1650-8. PubMed ID: 16601981
[TBL] [Abstract][Full Text] [Related]
24. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of retinoic acid on experimental autoimmune uveoretinitis.
Keino H; Watanabe T; Sato Y; Okada AA
Br J Ophthalmol; 2010 Jun; 94(6):802-7. PubMed ID: 19965837
[TBL] [Abstract][Full Text] [Related]
26. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin.
Kohno H; Sakai T; Saito S; Okano K; Kitahara K
Exp Eye Res; 2007 Mar; 84(3):569-76. PubMed ID: 17208229
[TBL] [Abstract][Full Text] [Related]
27. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
28. Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations.
Kerr EC; Raveney BJ; Copland DA; Dick AD; Nicholson LB
J Autoimmun; 2008 Dec; 31(4):354-61. PubMed ID: 18838247
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
30. Differential CD28 and inducible costimulatory molecule signaling requirements for protective CD4+ T-cell-mediated immunity against genital tract Chlamydia trachomatis infection.
Marks E; Verolin M; Stensson A; Lycke N
Infect Immun; 2007 Sep; 75(9):4638-47. PubMed ID: 17635872
[TBL] [Abstract][Full Text] [Related]
31. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
Ozkaynak E; Gao W; Shemmeri N; Wang C; Gutierrez-Ramos JC; Amaral J; Qin S; Rottman JB; Coyle AJ; Hancock WW
Nat Immunol; 2001 Jul; 2(7):591-6. PubMed ID: 11429542
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming.
Sartani G; Silver PB; Rizzo LV; Chan CC; Wiggert B; Mastorakos G; Caspi RR
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2211-8. PubMed ID: 8843907
[TBL] [Abstract][Full Text] [Related]
33. Prevention of experimental autoimmune uveoretinitis by blockade of osteopontin with small interfering RNA.
Iwata D; Kitamura M; Kitaichi N; Saito Y; Kon S; Namba K; Morimoto J; Ebihara A; Kitamei H; Yoshida K; Ishida S; Ohno S; Uede T; Onoé K; Iwabuchi K
Exp Eye Res; 2010 Jan; 90(1):41-8. PubMed ID: 19766630
[TBL] [Abstract][Full Text] [Related]
34. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis.
Gregerson DS; Torseth JW; McPherson SW; Roberts JP; Shinohara T; Zack DJ
J Immunol; 1999 Jul; 163(2):1073-80. PubMed ID: 10395707
[TBL] [Abstract][Full Text] [Related]
35. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma.
Chen YQ; Shi HZ
Allergy; 2006 Jan; 61(1):15-26. PubMed ID: 16364152
[TBL] [Abstract][Full Text] [Related]
36. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.
Mochizuki M; Kuwabara T; McAllister C; Nussenblatt RB; Gery I
Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):1-9. PubMed ID: 3967952
[TBL] [Abstract][Full Text] [Related]
37. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
38. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
[TBL] [Abstract][Full Text] [Related]
39. Role for inducible costimulator in control of Salmonella enterica serovar Typhimurium infection in mice.
Vidric M; Bladt AT; Dianzani U; Watts TH
Infect Immun; 2006 Feb; 74(2):1050-61. PubMed ID: 16428752
[TBL] [Abstract][Full Text] [Related]
40. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]